DADC
SGNT

D.A. Davidson & Co’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

D.A. Davidson & Co’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-250
Closed -$3K – 2558
2016
Q2 		$3K Hold
250
– – ﹤0.01% 2234
2016
Q1 		$3K Hold
250
– – ﹤0.01% 2137
2015
Q4 		$3K Buy
+250
New +$3.94K ﹤0.01% 2113

D.A. Davidson & Co's SGNT Position: Q3 2016 in Review

D.A. Davidson & Co sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 250 shares — an estimated $3K sold.

D.A. Davidson & Co first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $3K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • D.A. Davidson & Co reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 250 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $3K.
  • D.A. Davidson & Co first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • D.A. Davidson & Co's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on D.A. Davidson & Co's 13F filing for Q3 2016, filed 14 Nov 2016.